BMDMs and BMDCs than in WT cells (Supplementary
. Given that zymosan activates both TLR2 and dectin-1 (ref. 15 ), this result suggests that CBLB could regulate the dectin-1 signaling pathway. To directly test this we stimulated WT and Cblb −/− BMDMs and BMDCs with curdlan, a purified β-glucan that specifically activates dectin-1 (ref. 16) . Curdlan stimulation induced a markedly higher level of TNF-α and IL-6 in Cblb −/− BMDMs and BMDCs than in WT cells ( Supplementary Fig. 1a,b) .
To confirm this observation and to determine whether CBLB regulates other dectin family members, we infected BMDMs, BMDCs, and BM neutrophils from WT and Cblb −/− mice with a C. albicans yeast-only mutant (cap1; hereafter referred to as yeast), in which the adenylatecyclase-associated protein-1 (Cap1) gene was disrupted, causing the failure of yeast-hypha transition due to the lack of cAMP 17 . Dectin-1 and dectin-2 recognize the yeast and hyphal forms of C. albicans, respectively, by binding to the surface β-glucans (dectin-1) and αmannans (dectin-2) of the two fungal forms [2] [3] [4] . CBLB deficiency resulted in increased production of TNF-α and IL-6 by BMDMs and BMDCs in response to signaling via both the yeast and hyphal forms of C. albicans after infection ( Fig. 1a and Supplementary Fig. 2a ). In contrast, Cblb −/− neutrophils produced comparable amounts of TNFα and IL-6 to those produced in WT neutrophils, except at the 3-h time point after infection (Supplementary Fig. 2b ), suggesting that CBLB may have a limited role in affecting the inflammatory response of neutrophils to C. albicans infection. Cblb −/− BMDMs also produced more TNF-α and IL-6 than WT BMDMs infected with Aspergillus fumigatus conidia (Fig. 1b) , a prevalent fungus that causes potentially lethal infections in immunosuppressed patients 18 . This finding is notable, as dectin-1 is a major PRR recognizing A. fumigatus [19] [20] [21] . Therefore, CBLB has the potential to regulate the dectin family of CLRs in response to some fungal pathogens. Because several studies have indicated that either the NLRP3 inflammasome or a noncanonical, caspase-8-mediated inflammasome participates in host defense to C. albicans infection 22,23 , we measured IL-1β production by WT and Cblb −/− BMDMs after infection with C. albicans yeast and hyphae. Both WT and Cblb −/− BMDMs produced comparable levels of IL-1β ( Fig. 1a) , suggesting that CBLB does not regulate the inflammasome activation that is mediated by dectin-1 or dectin-2.
A recent report showed that β-glucan of C. albicans induces a strong IL-1RA response in human peripheral blood mononuclear cells (PBMCs), which is independent of dectin-1 and complement receptor 3 (CR3) 24 . To test whether CBLB affects the release of antiinflammatory stimuli such as IL-1RA, we measured the production of IL-1RA in BMDMs from WT and Cblb −/− mice after infection with live C. albicans yeast and hyphae. Our data showed that there was no significant difference in IL-1RA release between WT and Cblb −/− BMDMs infected with both forms of C. albicans (Fig. 1c) . These data suggest that CBLB does not modulate the release of IL-1RA.
To determine whether CBLB has a similar effect on human macrophages infected with C. albicans, human monocyte-derived macrophages (hMDMs) were generated 25, 26 and transfected with a Cblb-specific siRNA or a control scrambled siRNA. Consistent with the mouse results, we found that silencing Cblb in hMDMs resulted in markedly increased production of TNF-α and IL-6 after infection with C. albicans yeast and hyphae, with IL-6 production being more profound ( Supplementary Fig. 3a,b) . These results also correlated with impaired down-modulation of dectin-1 and dectin-2 expression ( Supplementary Fig. 3d ), thus indicating that our observations in mouse macrophages can be recapitulated in human macrophages.
CBLB binds to dectin-1 and dectin-2 in macrophages after infection with C. albicans Dectin family CLRs have a major role in fungal recognition and host innate responses against fungal infection 15, 27, 28 . Dectin-1's cytoplasmic tail contains an immunoreceptor tyrosine-based activation motif (ITAM) that can be phosphorylated by Src family kinases. Phosphorylated dectin-1 in turn, recruits and activates SYK, thereby initiating downstream signaling via the CARD9-BCL10-MALT1 [30] [31] [32] . We sought to determine whether and how CBLB regulates signaling via dectin-1 and dectin-2 during C. albicans infection. First, we determined whether CBLB physically interacts with dectin receptors or their signaling intermediates, and if so, how this occurs. To this end, we infected WT BMDMs with C. albicans yeast cells or hyphae for different amounts of time. We found, using co-immunoprecipitation (co-IP) analyses, that CBLB was inducibly associated with dectin-1, dectin-2, SYK, and CARD9 after infection with C. albicans yeast cells or hyphae ( Fig. 2a,b ). It has previously been shown that CBLB binds to SYK in B cells after B cell receptor (BCR) stimulation 33 or to CARD11 (also known as CARMA1), a homolog of CARD9, in NKT cells 34 . To determine whether SYK and CARD9 are potential binding partners of CBLB in the signaling pathways downstream of dectin-1 and dectin-2, we silenced Syk gene expression in WT BMDMs by using a Syk-specific siRNA. We found that knocking down Syk expression did not affect the association of CBLB with either dectin-1 or dectin-2 ( Fig. 2c) . Similarly, CARD9 deficiency also did not affect CBLB-dectin-1 or CBLB-dectin-2 association (Fig. 2d ). Next we wanted to determine whether phosphorylation of the ITAM within dectin-1 and the ITAMs within the IgE high-affinity receptor FcR-γ (encoded by Fcerg1 in mice) is required for CBLB association in macrophages after C. albicans infection (with yeast cells and hyphae). To accomplish this, we mutated the tyrosine of the hemi-ITAM to phenylalanine in dectin-1's cytoplasmic tail (CLEC7A Y15F ) and the tyrosines within the ITAMs of FcR-γ to phenylalanine (FCER1G Y65F,Y76F ), then reconstituted Clec7a −/− BMDMs and Fcerg1 −/− BMDMs with these mutated alleles and infected them with C. albicans yeast and hyphae, respectively. Mutating dectin-1 at Tyr15, or FcR-γ at Tyr65 and Tyr76, completely abrogated the binding of CBLB to dectin-1 or dectin-2 ( Fig. 2e,f) , indicating that phospho-Tyr15 of dectin-1 or phospho-Tyr65 and phospho-Tyr76 of FcR-γ is critical for their binding to CBLB. Indeed, CBLB bound to FcR-γ in WT BMDMs after infection with C. albicans hyphae ( Fig. 2g) .
Dectin-1, dectin-2, and SYK are targets of CBLB To determine whether dectin-1 and dectin-2, or the downstream signaling molecules, are the targets of CBLB, we first examined protein stability of dectin-1, dectin-2, SYK, and CARD9 in macrophages infected with C. albicans yeast cells or hyphae. Notably, dectin-1 and dectin-2, but not SYK or CARD9, underwent degradation in WT BMDMs after infection with C. albicans yeast cells and hyphae, but not in BMDMs lacking CBLB (Fig. 3a) . These findings suggest that dectin receptors are the likely targets of CBLB. Furthermore, dectin-1 and dectin-2 degradation was completely abrogated by pretreatment with E-64, a lysosome inhibitor, but not with MG-132, a proteasome inhibitor ( Fig. 3b ), suggesting that dectin-1 and dectin-2 undergo lysosome-mediated degradation. npg To further determine whether CBLB is the E3 ubiquitin ligase for dectin-1 or dectin-2, BMDMs generated from WT mice, Cblb −/− mice, or mice expressing an E3-ligase-dead mutant of CBLB (Cblb C373A ) 35 were infected with C. albicans yeast cells or hyphae. Expression of the CBLB C373A mutant abrogated ubiquitination of dectin-1 and dectin-2 ( Fig. 3c,d , upper panel, and Supplementary Fig. 4a,b , upper panel). To determine whether ubiquitination of dectin-1 or dectin-2 is K48-or K63-linked, we used K48-ubiquitin-or K63-ubiquitinspecific antibodies. We confirmed that both dectin-1 and dectin-2 underwent K48-linked polyubiquitination, and that this K48-linked polyubiquitination of dectin-1-and dectin-2 was abrogated in BMDMs lacking CBLB or expressing the CBLB C373A mutant ( Fig. 3c,d , bottom, and Supplementary Fig. 4a,b , top, and data not shown).
It was previously shown that CBLB targets SYK for polyubiquitination but not for degradation in B cells 33 . To determine whether SYK is also a potential target of CBLB in macrophages triggered by dectin-1 or dectin-2 receptor-ligand interactions, we examined SYK ubiquitination in WT and Cblb C373A -expressing BMDMs after infection with C. albicans yeast cells or hyphae. Indeed, SYK underwent K48-linked polyubiquitination after Clec7a npg infection with both C. albicans yeast and hyphae, but this ubiquitination was greatly reduced in BMDMs expressing CBLB C373A (Supplementary Fig. 4c,d) . Therefore, our data suggest that dectin-1, dectin-2, and SYK are targets of CBLB and that CBLB keeps the expression of these CLRs in check.
Consistent with these data, SYK and the transcription factor NF-κB were highly activated in BMDMs lacking CBLB after infections with C. albicans yeast and hyphae (Supplementary Fig. 4e) .
To examine the functional relevance of CBLB-mediated ubiquitination of dectin-1 and dectin-2, we used site-directed mutagenesis to generate single and triple lysine-to-arginine mutations in the genes encoding dectin-1 and dectin-2 (to yield CLEC7A K2R , CLEC7A K27R , CLEC7A K34R , CLEC7A K2R,K27R,K34R , and CLEC4N K10R ). We reconstituted BMDMs lacking dectin-1 (from Clec7a −/− mice) with constructs expressing either WT dectin-1 or the dectin-1 lysine-to arginine mutants and BMDMs lacking dectin-2 (from Clec4n −/− mice) with a construct expressing either WT dectin-2 or the CLEC4N K10R mutant. We then infected these reconstituted BMDMs with C. albicans yeast cells or hyphae. Reconstituting Clec7a −/− BMDMs with WT dectin-1 or the single mutants completely or partially restored dectin-1 ubiquitination; however, expression of the dectin-1 triple mutant did not result in dectin-1 ubiquitination (Fig. 3e) . As expected, Clec4n −/− BMDMs expressing WT dectin-2, but not the dectin-2 mutant (CLEC4N K10R ), restored ubiquitination of dectin-2 (Fig. 3f) .
These data indicate that Lys2, Lys7, and Lys34 in dectin-1 and Lys10 in dectin-2 are the sites of ubiquitination in dectin-1 and dectin-2, respectively. Consistent with these data, Clec7a −/− BMDMs expressing the dectin-1 triple mutant (CLEC7A K2R,K27R,K34R ) or Clec4n −/− BMDMs reconstituted with CLEC4N K10R produced significantly higher amounts of TNF-α and IL-6 after infection with C. albicans yeast cells or hyphae (Fig. 3g,h) .
CBLB regulates the internalization of dectin-1 and dectin-2, and their trafficking to the lysosome Cell surface receptor internalization can occur when receptors are mono-or polyubiquitinated following ligand-induced activation, and these receptors are subsequently sorted into endocytic vesicles for delivery to the lysosome for degradation [36] [37] [38] . Internalization of dectin-1 has been shown to terminate inflammatory responses to keep inflammation in check 39 . Thus, impaired down-modulation of dectin-1 and dectin-2 could be due to a lack of internalization or a block in intracellular vesicle sorting to the lysosome. To determine whether CBLB is critical for this process, the levels of cell-surface-expressed and npg internally expressed dectin-1 and dectin-2 in BMDMs from WT and Cblb −/− mice were investigated. We found a minimal level of intracellular dectin-1 or dectin-2 in Cblb −/− BMDMs (Fig. 4a,b ), suggesting that CBLB promotes internalization of dectin-1 or dectin-2 after infection with C. albicans yeast cells or hyphae. We next investigated whether retention of ligand-engaged dectin-1 or dectin-2 in Cblb −/− BMDMs is due to impaired sorting of endosomal vesicles to lysosomes. We compared the subcellular localization of ligand-engaged dectin-1 or dectin-2 in WT and Cblb −/− BMDMs by confocal microscopy. In support of the idea of impaired lysosomal degradation of dectin-1 and dectin-2 in BMDMs lacking CBLB, intracellular trafficking of internalized dectin-1 or dectin-2 to the lysosome was markedly reduced in the absence of CBLB (Fig. 4c,d) .
CBLB negatively regulates ROS production and fungal killing but not phagocytosis of C. albicans Neutrophils and macrophages are professional phagocytes of the innate immune system that are essential in controlling bacterial and fungal infections by phagocytosis and killing mechanisms 40 . The production of highly reactive oxygen species (ROS) is one of the primary effector mechanisms used by phagocytes to control or clear microbial infections. ROS have an important role in the initial step of fungal killing in phagosomes 41 and can be potentiated by dectin signaling. We measured ROS production by co-culturing the C. albicans cap1 mutant yeast or hyphae with WT or Cblb −/− BMDMs. We found that Cblb −/− and Cblb C373A -expressing BMDMs produced more ROS than WT controls at a multiplicity of infection (MOI) of 5:1 or 2:1 ( Supplementary  Fig. 5a ). Enhanced ROS activity in Cblb −/− BMDMs correlated with an increase in their fungal-killing potency (Supplementary Fig. 5b) . Consistent with a limited role of CBLB in pro-inflammatory cytokine production by neutrophils, we did not observe a substantial increase in ROS activity and fungal killing in neutrophils that were isolated from the BM of Cblb −/− or Cblb C373A -expressing mice, as compared to those in the WT controls (Supplementary Fig. 5c) of C. albicans by Cblb −/− BMDMs was not increased, as compared to that by WT BMDMs (Supplementary Fig. 5d ).
CBLB inhibits dectin-mediated innate immune responses to systemic C. albicans infection
The recognition of β-glucans and α-mannans by dectin-1 and dectin-2, respectively, is thought to trigger immune responses that are primarily designed for the control of fungal pathogens [2] [3] [4] . To assess the role of CBLB in antifungal immunity, we infected WT, Cblb −/− , and Cblb C373A -expressing mice with a lethal dose of C. albicans to monitor survival and with a sublethal dose to measure serum cytokines and fungal burden. We found that most Cblb −/− and Cblb C373A -expressing mice were protected from lethal systemic infection with C. albicans (Fig. 5a) , which correlated with heightened levels of TNF-α and IL-6 in the sera of Cblb −/− and Cblb C373A -expressing mice, lower fungal burden in the kidney, lung, spleen, and liver, and decreased amounts of C. albicans hyphae in the kidney on day 2 as assessed by PAS staining (Fig. 5b-d and Supplementary Fig. 6a ). We also observed multifocal tubulointerstitial nephritis in WT mice infected with C. albicans, which was ameliorated in mice lacking CBLB or expressing the CBLB C373A mutant (Fig. 5c) . This observation is consistent with the fact that more immune cells-including macrophages, DCs, and neutrophils-traffic to the kidneys in WT than in Cblb C373A -expressing mice (Supplementary Fig. 6b ). An improved survival rate was also observed in Rag1 −/− Cblb −/− mice that lack functional adaptive immune cells (Fig. 5e) , supporting a critical role of CBLB in downregulating innate immune responses.
To further determine whether monocytes, macrophages, and neutrophils have a greater capacity to kill C. albicans during systemic infection, we monitored fungal burdens in the blood of WT and Cblb C373A -expressing mice at 2 h and 6 h after infection. We found that fungal burden in the blood of Cblb C373A -expressing mice was substantially lower than that of WT mice at 2 h and 6 h after infection (Supplementary Fig. 7a) . The lower fungal burden in the blood of Cblb C373A -expressing mice correlated with enhanced fungal killing activity by PBMCs but not by neutrophils in these mice ( Supplementary  Fig. 7a ). Increased fungal killing was also observed in monocytes from the spleen of Cblb C373A -expressing mice (Supplementary Fig. 7b ). We also monitored ROS activity in monocytes, macrophages and neutrophils from WT and Cblb C373A spleens and kidneys by CellRox dye (Supplementary Fig. 7c ). Monocytes and macrophages, but not neutrophils, showed augmented ROS expression in C. albicans-infected Cblb C373A -expressing mice after they were infected in vitro with C. albicans. Consistent with the lower fungal burden and decreased inflammation in Cblb C373A kidneys, trafficking of CD45.2 + leukocytes, including macrophages, DCs, and neutrophils, to Cblb C373A kidneys was significantly reduced (Supplementary Fig. 6b ; P < 0.01). Even with decreased numbers of myeloid cells in Cblb C373A kidneys after infection with C. albicans, we observed an increase in ROS expression in monocytes and macrophages, increased fungal killing in vitro using CD45 + cells isolated from Cblb C373A kidneys (Supplementary Fig. 7d) , and increased amounts of TNF-α and IL-6 in the kidney homogenates of Cblb C373A -expressing mice (Supplementary Fig. 7e) .
To further determine whether heightened inflammatory responses caused by CBLB deficiency are mediated by dectin-1 and dectin-2, we generated Cblb
Dectin-1 or dectin-2 single deficiency rendered Cblb −/− mice susceptible to C. albicans infection, and a deficiency in both dectin-1 and dectin-2 greatly increased the sensitivity of Cblb −/− mice to systemic C. albicans infection. All of the triple-knockout mice died within 4 d after infection at a dose at which all of the Cblb −/− mice survived (Fig. 5f) , which correlated with markedly lower levels of TNF-α and IL-6 in their sera and a lower fungal burden in the kidneys of the triple-knockout mice (Supplementary Fig. 8a,b) . Therefore, our results suggest that CBLB negatively regulates both dectin-1 and dectin-2, and that CBLB dampens inflammatory responses mediated by dectin-1 and dectin-2 during systemic fungal infection. Notably, Cblb −/− or Cblb C373A mice at 8-12 weeks of age did not show signs of autoimmunity, as revealed by comparable amounts of autoantibody titers to double-stranded (ds) DNA and single-stranded (ss) DNA, and of IL-17 and IFN-γ levels, in the sera of WT and Cblb −/− or Cblb C373A mice, as well as no elevated IL-17 and IFN-γ in the kidneys of Cblb −/− or Cblb C373A mice, as compared to that of WT mice (Supplementary Fig. 9a-d) . These data suggest that a pre-existing autoimmunity in Cblb −/− or Cblb C373A mice does not account for strong differences in antifungal immune responses, relative to those in WT mice, after fungal infection.
We also observed that Clec7a −/− and Clec4n −/− mice die at a similar rate after systemic C. albicans infection, suggesting that both dectin-1 and dectin-2 are equally important for fungal recognition (Fig. 5f) . Because Cblb −/− Clec7a −/− , Cblb −/− Clec4n −/− , and Cblb −/− Clec7a −/− Clec4n −/− mice did not die at the same rate after infection as did Clec7a −/− , Clec4n −/− , or Clec7a −/− Clec4n −/− mice (Fig. 5f) , these results suggest that CBLB may regulate an additional CLR(s), such as the mannose receptor (MR), dectin-3, or Mincle, which have been shown to be involved in host defense against C. albicans infection 4, [42] [43] [44] . Indeed, loss of CBLB appeared to stabilize the protein expression of dectin-3, but not MR, Mincle and dendritic-cell-specific intercellular-adhesion-molecule-3-grabbing non-integrin (DC-SIGN) (Supplementary Fig. 10) . npg CBLB is a potential therapeutic target for antifungal infection Because CBLB downregulates dectin family CLR signaling and host innate immune responses, decreasing CBLB expression may enhance phagocyte antifungal responses, providing evidence for a new therapeutic approach. We performed experiments using in vivo delivery of Cblb-specific siRNA to knock down Cblb. We first infected WT mice with C. albicans by intravenous (i.v.) injection, and 24 h later we injected the Cblb-specific siRNA or a nonsense siRNA via the tail vein. Mortality of the mice was monitored for 7 d. Although all of the WT mice that were treated with the nonsense siRNA died within 7 d after infection, seven of nine WT mice that were treated with the siRNA to Cblb survived. There was a significantly higher fungal burden in the kidneys of WT mice that received the nonsense siRNA than those that received the Cblb-specific siRNA (Fig. 6) . These data indicate that CBLB may serve as a potent therapeutic target for enhancing host defense against fungal infections.
DISCUSSION
The fungal cell wall consists mainly of carbohydrates, including mannose-based structures (the mannoproteins), β-glucan, and chitin. Recognition of β-glucans and α-mannans by dectin-1 and dectin-2 is essential for antifungal immunity 27 . However, the regulation of dectin family receptors is unknown. Here we show that CBLB functions as a negative regulator of the dectin-1 and dectin-2 CLRs, which initiate innate immune responses to fungal pathogens in human and mouse macrophages. CBLB targets dectin-1 and dectin-2, and SYK for K48-linked polyubiquitination, which inhibits dectin-1-or dectin-2mediated signaling pathways. CBLB deficiency or inactivation leads to increased pro-inflammatory responses that decrease dissemination of C. albicans and bolster host defense. To our knowledge, our findings are the first to identify a negative regulator of dectin-receptor-mediated innate immune responses. We show that CLEC7A K2R, K27R, K34R and CLEC4N K10R mutants, in which ubiquitination is abrogated, result in increased production of TNFα and IL-6 by macrophages infected with C. albicans yeast cells or hyphae (Fig. 3g,h) , thus mirroring the data obtained from Cblb −/− and Cblb C373A mice. Our data therefore provide evidence that ubiquitination of dectin-1 and dectin-2 is a key mechanism for terminating innate immune responses during fungal infection, thereby avoiding excessive inflammation and subsequent tissue damage, while at the same time dampening optimal host-defense properties.
Phagocytosis is a key cellular process, both during homeostasis and after infection or tissue damage, and dectin-1 has been shown to be a phagocytic receptor 45 . ROS production by phagocytes is associated with pathogen killing 46 , and it was reported that dectin-1 activates SYK in macrophages and is important for dectin-1-stimulated ROS production, but not for phagocytosis 47 . Consistent with this report, our data show that CBLB regulates both dectin-1 and dectin-2 expression, and ROS production, by macrophages but does not affect fungal phagocytosis (Supplementary Fig. 5 ). Our data suggest that additional receptor(s), such as those belonging to the Fc-γ receptor family or DC-SIGN 44, 45 , may be involved in controlling fungal phagocytosis independently of regulation by CBLB.
Because CBLB is critical for T cell activation, tolerance induction, and T H 2 and T H 9 cell differentiation 6 , it is possible that the enhanced antifungal immune response in the absence of CBLB may result in heightened adaptive T cell responses. However, this possibility was excluded by the observation that the phenotype of Cblb −/− Rag1 −/− mice, which do not have T and B cells, phenocopies that of Cblb −/− mice after C. albicans infection (Fig. 5e) , supporting the notion that CBLB is crucial for controlling innate immune responses against systemic C. albicans infection. We also further demonstrate that the heightened innate immune responses observed during systemic C. albicans infection is mediated by dectin-1 and dectin-2, because introducing mutants of dectin-1, dectin-2, or both into Cblb −/− mice abrogates these heightened responses and renders Cblb −/− mice susceptible to C. albicans infection ( Fig. 5f and Supplementary  Fig. 8a) . More notably, systemic in vivo delivery of a Cblb-specific siRNA to C57BL/6 mice protects them from lethal systemic C. albicans infection (Fig. 6) . These data suggest that CBLB is a potential therapeutic target for controlling disseminated candidiasis. Of note, inhibition of CBLB may have detrimental effects due to unchecked inflammation, particularly on patients in intensive care. However, inhibition of Cblb by using an siRNA in vivo may be a more viable approach because the siRNA would have a limited half-life and dosages could be modulated to minimize the degree of inflammation. In addition, no signs of autoimmunity were observed in Cblb −/− or Cblb C373A -expressing mice (Supplementary Fig. 9 ). However, given that we have shown that Cblb −/− mice develop severe airway inflammation and an aberrant T H 2 response in an ovalbumin-induced asthma model 14 , it would be interesting to test whether mice deficient for CBLB or expressing CBLB C373A are susceptible to allergic bronchopulmonary aspergillosis.
In summary, our data provide the first evidence that CBLB has an essential role in regulating dectin-mediated innate immune responses to fungal pathogens following inflammatory responses to fungi in immunocompetent hosts. One consequence of this dampening of inflammatory responses is the creation of a less-than-optimal host defense program. Targeting CBLB may therefore serve as a new therapeutic strategy in fighting fungal infections.
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